Aster Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22
Closed -$1.2K 1187
2025
Q3
$1.2K Buy
+22
New +$1.1K ﹤0.01% 893
2025
Q2
Sell
-2,637
Closed -$125K 1213
2025
Q1
$125K Buy
2,637
+2,554
+3,077% +$129K 0.02% 589
2024
Q4
$4.66K Sell
83
-11,016
-99% -$686K ﹤0.01% 869
2024
Q3
$756K Buy
+11,099
New +$626K 0.16% 154

Other funds holding EXAS

Aster Capital Management's EXAS Position: Q4 2025 in Review

Aster Capital Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 22 shares — an estimated $1.2K sold.

Aster Capital Management first reported a position in EXAS in Q3 2024 and held it in 4 quarters. The position peaked at $756K in Q3 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Aster Capital Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Aster Capital Management sold 22 Exact Sciences shares in Q4 2025, an estimated $1.2K.
  • Aster Capital Management first reported a position in Exact Sciences in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Exact Sciences position peaked at $756K in Q3 2024.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.